Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sidoni

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2008
Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survivalV Ludovini, S Gori, M Colozza, et al.
British Journal of Cancer|January 8, 2004
Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancerS Gori, M Colozza, A M Mosconi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2009
EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumabS Gori, A Sidoni, M Colozza, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2012
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutationsV Ludovini, F Bianconi, L Pistola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patientsV Ludovini, G Bellezza, L Pistola, et al.
Breast Cancer Research and Treatment|October 24, 2003
Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patientsV Ludovini, A Sidoni, L Pistola, et al.
Cancer Chemotherapy and Pharmacology|January 15, 2013
Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patientsV Ludovini, A Flacco, F Bianconi, et al.
ESMO Open|February 3, 2026
Incidence and risk factors of brain metastases in radically resected melanoma patients: a large international cohort studyM Mandalà, P Rutkowski, R Patuzzo, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2008
Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survivalV Ludovini, S Gori, M Colozza, et al.
British Journal of Cancer|January 8, 2004
Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancerS Gori, M Colozza, A M Mosconi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2009
EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumabS Gori, A Sidoni, M Colozza, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2012
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutationsV Ludovini, F Bianconi, L Pistola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patientsV Ludovini, G Bellezza, L Pistola, et al.
Breast Cancer Research and Treatment|October 24, 2003
Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patientsV Ludovini, A Sidoni, L Pistola, et al.
Cancer Chemotherapy and Pharmacology|January 15, 2013
Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patientsV Ludovini, A Flacco, F Bianconi, et al.
ESMO Open|February 3, 2026
Incidence and risk factors of brain metastases in radically resected melanoma patients: a large international cohort studyM Mandalà, P Rutkowski, R Patuzzo, et al.
Pageof 6